Skip to content
Governance Register

← US public companies

Spero Therapeutics, Inc.

SEC CIK 1701108 · SPRO · last insider filing 2026-06-25

Directors (from insider filings)

NameCapacity as filedFilings
Thomas Frank E Director filed 2017 - 2026
Pottage John C Jr Director filed 2018 - 2026
Deshpande Milind Director filed 2017 - 2026
Vink Patrick V.J.J. Director filed 2017 - 2026
Jackson Scott Thomas Director filed 2020 - 2026
Smith Cynthia Director filed 2019 - 2026
Tregoning Kathleen Director filed 2021 - 2026
Mahadevia Ankit Director · See Remarks filed 2017 - 2025
Shukla Sath Director · Chief Financial Officer filed 2021 - 2025
Formela Jean Francois Director filed 2017 - 2021
Southwell David P Director filed 2018 - 2018
Breum Casper Director filed 2017 - 2018
Goyal Vikas Director filed 2017 - 2017
Halse Reza Director filed 2017 - 2017

Officers (from insider filings)

NameTitle as filedFilings
Rajavelu Esther See Remarks filed 2023 - 2026
Keutzer Timothy Chief Operating Officer filed 2020 - 2026
Joseph Tamara L Chief Legal Officer filed 2020 - 2024
Hamed Kamal Chief Medical Officer filed 2022 - 2024
Dipalma Stephen J. See Remarks filed 2019 - 2023
Larkin Cristina Chief Operating Officer filed 2017 - 2022
Melnick David A. Chief Medical Officer filed 2018 - 2022
Parr Thomas R JR Chief Scientific Officer filed 2017 - 2019
Sendek Joel Chief Financial Officer filed 2017 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.